Systemic Anti-Cancer Therapy Regimen Library
Neuroendocrine Regimens

Adrenocortical carcinoma Regimens
No regimens currently in this group
Neuroendocrine carcinoma Regimens

Published
Name
![]() |
Version
![]() |
Date
![]() |
---|---|---|
Neuroendocrine carcinoma - cISplatin and etoposide 60/120 chemoradiation | 1.0.0 | 18/09/2023 |
Neuroendocrine carcinoma - cISplatin and etoposide 80/100 chemoradiation | 1.0.0 | 18/09/2023 |
Neuroendocrine carcinoma Advanced - cARBOplatin and etoposide | 1.0.0 | 11/09/2023 |
Neuroendocrine carcinoma Advanced - cARBOplatin and oral etoposide | 1.0.0 | 11/09/2023 |
Neuroendocrine carcinoma Advanced - CETUximab [Q2W] and encorafenib | 1.0.0 | 21/04/2025 |
Neuroendocrine carcinoma Advanced - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [high dose foliNIc acid] | 1.0.0 | 21/09/2023 |
Neuroendocrine neoplasm Regimens

Published
Neuroendocrine tumour Regimens

Published
Name
![]() |
Version
![]() |
Date
![]() |
---|---|---|
Neuroendocrine tumour Advanced - everolimus | 1.0.0 | 11/09/2023 |
Neuroendocrine tumour Advanced - lanreotide | 1.0.0 | 28/04/2025 |
Neuroendocrine tumour PANC Advanced - sUNITinib | 1.0.0 | 11/09/2023 |